Home > Healthcare > Medical Devices > Diagnostic Devices > urine flow meters market
Get a free sample of Urine Flow Meters Market
Your inquiry has been received. Our team will reach out to you with the required details via email. To ensure that you don't miss their response, kindly remember to check your spam folder as well!
Form submitted successfully!
Error submitting form. Please try again.
Get a free sample of Urine Flow Meters Market
Your inquiry has been received. Our team will reach out to you with the required details via email. To ensure that you don't miss their response, kindly remember to check your spam folder as well!
Form submitted successfully!
Error submitting form. Please try again.
Based on type, the wired connection type segment held is poised to reach USD 28.9 million by 2032.
Based on product, the portable segment is likely to cross USD 23.2 million by 2032.
Based on application, the BPH segment held leading revenue share in 2023 and is anticipated to reach USD 12.6 million by 2032.
The urine flow meters market by end-use is categorized into hospitals, clinics, home health care settings and others. The hospital segment exceeded USD 12.5 million in 2023.
North America urine flow meters market accounted for over USD 10.3 million in 2023 and is predicted to witness substantial market growth.
The wired connection segment is expected to reach USD 28.9 million by 2032, due to factors such as familiarity, perceived reliability, accuracy, compatibility, or personal comfort.
The market size of urine flow meters reached USD 25.9 million in 2023 and is set to cross USD 48.5 million by 2032, owing to the increasing prevalence of urological disorders such as, urinary tract infections (UTIs), urolithiasis, and benign prostatic hyperplasia (BPH) worldwide.
Apex Meditech (India), CellSonic Medical, Cognitix, Dantec Medical, Digitimer, EV. Services Italia SRL, Foresight Technology, Laborie (US), Medispec, and MCube Technology, are some of the major urine flow meters companies worldwide.
North America market was valued at USD 10.3 million in 2023, attributed to increase in aging population, leading to an increased risk of benign prostatic hyperplasia (BPH) and urinary incontinence in the region.